Equities

Precision System Science Co Ltd

7707:TYO

Precision System Science Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)267.00
  • Today's Change3.00 / 1.14%
  • Shares traded150.40k
  • 1 Year change-5.32%
  • Beta1.0317
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Precision System Science Co., Ltd. is engaged in the development, manufacture and sales of various devices for lab (laboratory) automation and clinical diagnosis. The equipment business provides various automated equipment for lab such as deoxyribonucleic acid (DNA) automatic extractors and others, immunochemical luminescence measuring devices, specimen pretreatment devices for clinical diagnosis, and fully automated gene diagnostic equipment, among others. The reagents and consumables business provide various reagents used for DNA extraction and protein purification, as well as dedicated plastic consumables such as reaction vessel and others. The maintenance-related segment is engaged in equipment maintenance business, and the sales of spare parts (replacement parts). The contract manufacturing business is engaged in the contract manufacturing business.

  • Revenue in JPY (TTM)3.98bn
  • Net income in JPY-1.12bn
  • Incorporated1985
  • Employees158.00
  • Location
    Precision System Science Co Ltd88, KamihongoMATSUDO-SHI 271-0064JapanJPN
  • Phone+81 473034800
  • Fax+81 473034810
  • Websitehttps://www.pss.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
KAWAMOTO CORPORATION31.26bn461.69m4.72bn436.009.870.620110.280.150979.6679.665,393.351,267.551.579.203.2471,691,000.002.134.034.037.7117.3017.791.362.371.3525.060.44511.19-2.544.66-46.2541.6216.7435.10
Kowa Co Ltd6.39bn726.57m4.80bn213.005.891.535.030.7506162.57162.571,414.88623.861.242.825.8729,992,250.0014.386.0623.339.1045.6846.3711.625.391.1013.550.276222.732.167.1962.08---10.57--
Data Horizon Co Ltd4.91bn-901.84m5.08bn374.00--1.76--1.04-71.15-71.15387.43226.700.699818.213.3813,130,090.00-13.14-8.40-20.33-12.1327.9039.93-18.77-7.731.17-46.560.5284--13.5317.28-21.41--64.50--
KAINOS Laboratories, Inc.5.24bn615.86m5.45bn146.008.170.77927.491.04146.29146.291,244.141,533.730.6323.243.2835,882,720.007.436.929.219.2650.1851.8411.7610.803.11--0.078419.622.711.6012.2810.57-9.8316.36
Aso International Inc3.60bn421.09m5.51bn276.0013.352.0614.551.5384.5284.52721.30546.461.2514.527.6513,039,030.0014.61--16.47--44.72--11.70--7.5939.33----11.12--14.27------
Yamashita Health Care Holdings Inc62.72bn501.00m5.65bn606.0011.180.64857.840.09197.83197.8324,816.183,411.072.6417.765.65103,493,400.002.112.235.746.4513.7412.460.79720.84721.01--0.0033.155.770.0071164.8432.063.8410.76
Leoclan Co Ltd19.80bn136.06m5.75bn176.0042.421.0322.630.290322.9622.963,346.78943.511.56368.493.41--1.222.192.384.8213.2210.820.78041.172.40-------25.64-11.32-49.85-28.60-19.34--
Precision System Science Co., Ltd.3.98bn-1.12bn7.39bn158.00--1.78--1.86-40.59-40.59144.04149.930.49261.585.4625,189,580.00-13.88-3.81-18.40-5.0923.8830.40-28.18-5.531.49-16.260.2488---24.60-1.9015.31---24.26--
Koken Ltd10.22bn565.86m7.90bn287.0013.510.60787.800.7729114.49114.492,066.952,545.070.49912.003.0135,597,010.002.763.703.414.7545.6946.695.547.191.8122.340.306825.88-0.16054.92-15.8414.33-39.876.96
Create Medic Co Ltd12.93bn888.98m8.75bn962.009.050.51955.690.6765100.05100.051,446.831,742.180.68071.724.6413,440,170.004.683.005.453.5343.7645.366.884.603.47--0.050663.222.103.11-68.06-25.530.66271.12
DVx Inc47.25bn55.70m9.55bn316.00166.261.0520.400.20215.335.334,522.33842.242.0623.294.13149,530,700.000.24323.110.58267.5710.2211.600.11791.491.42----47.57-3.442.57-81.53-29.2311.2315.81
EcoNaviSta Inc1.20bn281.96m10.77bn35.0042.313.3335.648.9838.6538.65170.53490.670.38961.5218.3634,260,280.009.16--9.85--66.17--23.51--15.45--0.00--21.55--38.02------
JMS Co Ltd67.87bn-36.00m10.93bn5.28k--0.26782.870.1611-1.47-1.472,772.011,650.800.82132.643.8012,847,620.00-0.05081.33-0.07381.9721.9524.29-0.06191.571.070.68320.383243.312.432.38-112.81---2.421.22
Data as of Nov 15 2024. Currency figures normalised to Precision System Science Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

0.39%Per cent of shares held by top holders
HolderShares% Held
Simplex Asset Management Co., Ltd.as of 03 Oct 2024107.50k0.39%
Data from 31 Oct 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.